Diethyl 4-(4-fluorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Catalog No.: 
ACXNVB823
CAS No.: 
58395-00-9
Molecular Formula: 
C19H22FNO4
Molecular Weight: 
347.39
Diethyl 4-(4-fluorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$147.00InquiryInquiry
5g97%$720.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDiethyl 4-(4-fluorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
IUPAC Namediethyl 4-(4-fluorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Molecular FormulaC19H22FNO4
Molecular Weight347.39
SMILESO=C(C1=C(C)NC(C)=C(C(OCC)=O)C1C2=CC=C(F)C=C2)OCC
InChI KeyAITJZYHNAKUCFP-UHFFFAOYSA-N
Synonym3,5-Pyridinedicarboxylic acid, 4-(4-fluorophenyl)-1,4-dihydro-2,6-dimethyl-, 3,5-diethyl ester;Diethyl 4-(4-fluorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
CAS No.58395-00-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXNVB823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXNVB823 route product structure diagram
    ACXNVB82358395-00-9
Inquiry

2. ACXNVB823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXNVB823 route product structure diagram
    ACXNVB82358395-00-9
Inquiry

3. ACXNVB823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXNVB823 route product structure diagram
    ACXNVB82358395-00-9
Inquiry

Comments (0)